Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS EQUITY (DEFICIT) (Details Narative)

v3.22.1
STOCKHOLDERS EQUITY (DEFICIT) (Details Narative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 21 Months Ended
Oct. 21, 2021
Oct. 15, 2021
Oct. 12, 2021
Oct. 11, 2021
Sep. 30, 2021
Jul. 02, 2021
Jun. 15, 2021
Jun. 02, 2021
May 28, 2021
Nov. 24, 2020
Nov. 11, 2020
Jan. 31, 2021
Nov. 29, 2019
Dec. 31, 2021
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Grants shares       7,660                              
Grants shares, amount       $ 33,549                              
Common stock and treasury shares, Description                 1-for-80 basis and (ii) decrease the number of total authorized shares of common stock of the Company from 1,200,000,000 to 150,000,000 shares. The Certificate of Amendment became effective at 12:01 a.m. (Eastern Time) on May 28, 2021 (the “Effective Time”).                    
Reverse stock split of common stock                 As of the Effective Time, every 80 shares of issued and outstanding common stock were converted into one share of common stock.   1-for-25 to 1-for-120                
Common stock purchased, related party           150,000                     4,464 46,807  
Proceed from related party           $ 748,500                     $ 50,000 $ 400,866  
Purchase price         $ 5.50 $ 4.99   $ 5.50                 $ 11.20 $ 8.56  
Other costs           $ 75,191   $ 1,622,638                      
Common stock unit issued               2,760,000                 79,813    
Gross proceeds of stock               $ 13,804,240                 $ 830,400 $ 1,254  
Common stock issued on warrant exercise, shares                                 108,562    
Net proceeds of stock         $ 1,091,767 $ 673,159   $ 12,181,602                 $ 20,000 $ 399,612  
Stock warrant exercised         198,503                       139,100 70,625  
Issuance of common stock                                 54,361 28,841  
Sale of common stock warrants, Shares               414,000                 5,626    
Sale of common stock warrants, Description               On June 2, 2021, the Company completed its public offering of common stock and warrants. As part of the transaction, the Company sold 414,000 warrants (“registered warrants”) with an exercise price of $5.50 per share, from the overallotment option that was exercised by the underwriter for $4,140. Additionally, the Company issued the underwriter 8% of the number of shares of common stock in the offering in 220,800 unregistered warrants for shares of common stock, for an aggregate price to the Company of $100. These warrants are exercisable 180 days after the offering date and expire five years after the first day they are exercisable. The warrants were valued at $946,675 based on the Black Scholes pricing model relying on the following assumptions: volatility 132.46%; annual rate of dividends 0%;  discount rate 0.80%. This was recognized by the company as an underwriting cost and was accounted for as an offset to funds raised.                      
Underwriters description                                 On July 2, 2021, the underwriter of the June 2021 Offering exercised its overallotment option and purchased an additional 150,000 shares of the Company’s stock at $4.99 per share for gross proceeds of $748,500, and net proceeds of $673,309 after related underwriting and other costs of $75,191.    
Professional fee                                 $ 710,481 $ 1,280,366  
Proceeds from warrant exercises                           $ 1,091,767 $ 1,091,767     0  
Proceed from stock issuances                                 1,514,970 400,866  
Sale of common stock warrants, Amount                                 50,000 0  
Dividend rate                                     0.00%
Common stock value                           $ 9,420     9,420 $ 5,163 $ 9,420
Minimum [Member]                                      
Discount rates                                     0.26%
Volatility range                                     129.13%
Maximum [Member]                                      
Discount rates                                     0.87%
Volatility range                                     154.26%
Black Scholes Pricing Model [Member]                                      
Dividend rate 0.00%   1.59%             0.00%               0.00%  
Discount rates 1.68%                 0.39%                  
Volatility range 141.38%                 148.83%                  
Common stock value $ 3,476,392   $ 50,000             $ 386,348               $ 495,501  
Black Scholes Pricing Model [Member] | Minimum [Member]                                      
Discount rates                                   0.41%  
Volatility range                                   128.20%  
Black Scholes Pricing Model [Member] | Maximum [Member]                                      
Discount rates                                   1.65%  
Volatility range                                   142.46%  
Three of its directors [Member]                                      
Exercise price                               $ 8.00      
Warrants purchase     50,000                         6,250      
Dividend rate                               0.00%      
Fair value of warrants                               $ 1,248,616      
Discount rates                               0.28%      
Volatility range                               144.93%      
Director fees                               $ 10,000      
Chairman [Member]                                      
Warrants purchase                               125,000      
Private Investors [Member]                                      
Proceed from stock issuances                                 $ 1,514,970 $ 1,254  
Shares issued                                 139,664 156  
2021 Incentive Plan [Member]                                      
Shares granted 260,000                 237,500                  
Option on shares                                 969,644    
Remained shares                                 30,356    
Share purchased 924,000                 37,500                  
Aggregate number of common shares available for issuance 664,000                 162,500                  
HEP Investments | Third Party Investors                                      
Proceed from related party     $ 50,000                             $ 425,000  
Exercise price                                 $ 8.00 $ 8.00  
Average price                                 $ 7.65    
Warrants purchase                                   53,125  
Participation Agreements [Member] | Black Scholes Pricing Model [Member]                                      
Sale of common stock warrants, Shares                                 5,626 100,689  
Sale of common stock warrants, Amount                                 $ 55,697 $ 897,805  
Dividend rate                                 0.00% 0.00%  
Participation Agreements [Member] | Black Scholes Pricing Model [Member] | Minimum [Member]                                      
Discount rates                                 0.41% 0.26%  
Volatility range                                 129.13% 129.13%  
Participation Agreements [Member] | Black Scholes Pricing Model [Member] | Maximum [Member]                                      
Discount rates     0.00%                           0.87% 0.87%  
Volatility range   0.00% 142.54%                           140.20% 154.26%  
Total options     $ 11,416                                
2019 Incentive Plan [Member]                                      
Aggregate number of common shares available for issuance                         1,275,000            
Option issued                         781,250            
Plan term                         10 years            
Issuance of additional options                         1,000,000            
Incentive plan, description                         Equity Incentive Plan, the Company maintained a 2019 Omnibus Long-Term Incentive Plan (the “2019 Plan”). Following the approval by the shareholders of the 2021 Equity Incentive Plan, no additional awards have been or will be made under the 2019 Plan. As of December 31, 2021, 781,250 stock options had been issued under the 2019 Plan with terms between 5 years and 10 years, of which 743,750 remained outstanding.            
Chief Financial Officer [Member]                                      
Option to purchase common stock                       162,500              
Options, grants in period, exercise price                       $ 11.20              
Chief Financial Officer [Member] | Tranche Two [Member]                                      
Options, vested and expected to vest, outstanding, number                       15,625              
Chief Financial Officer [Member] | Tranche One [Member]                                      
Options, vested and expected to vest, outstanding, number                       37,500              
CorProminence, LLC [Member]                                      
Market price   $ 4.15         $ 4.48                        
Common stock share issued, restricted   2,500         5,000                        
Total expense   $ 10,375         $ 22,400